BRONQUIOLITE OBLITERANTE E PNEUMONIA EM ORGANIZAÇÃO SECUNDÁRIA AO USO DE AMIODARONA BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA SECONDARY TO

Amiodarone is a widely used anti-arrhythmic agent in clinical practice. One of the potentially life threatening adverse effects is amiodarone-induced pulmonary toxicity (APT). We describe a case of a 63-year-old woman with APT. The diagnostic workup included pulmonary biopsy that demonstrated bronchiolitis obliterans organizing pneumonia (BOOP). Amiodarone was discontinued subsequently and corticosteroid treatment initiated, with clinical and radiological disease remission.